Bo Feng

Title: Bo Feng: Innovator in Reproductive Health

Introduction

Bo Feng is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of reproductive health through his innovative research and patents. With a total of 2 patents, his work focuses on utilizing neurotrophins to enhance reproductive capacity in female subjects.

Latest Patents

Bo Feng's latest patents include methods and kits designed for manipulating and predicting the reproductive capacity of a female subject. His research highlights the role of endogenous neurotrophins and the addition of exogenous neurotrophins, particularly BDNF, NT-4/5, and NGF. These neurotrophins increase the reproductive capacity of female patients by binding to receptors on oocytes and stimulating their maturation. Furthermore, the administration of antagonists can act as a contraceptive by preventing neurotrophins from binding to oocyte receptors. His methods also explore the potential of neurotrophins to stimulate oocyte maturation in vitro.

Career Highlights

Bo Feng is affiliated with the University of Medicine and Dentistry of New Jersey, where he continues to advance his research in reproductive health. His innovative approaches have garnered attention in the scientific community, contributing to the understanding of neurotrophins in reproductive biology.

Collaborations

Some of Bo Feng's notable coworkers include David B Seifer and Robert Shelden. Their collaborative efforts have further enriched the research landscape in reproductive health.

Conclusion

Bo Feng's work exemplifies the intersection of innovation and reproductive health. His patents and research contribute significantly to the understanding and manipulation of reproductive capacity, showcasing the potential of neurotrophins in this vital area of study.